279 related articles for article (PubMed ID: 1967919)
1. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
[TBL] [Abstract][Full Text] [Related]
2. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E
Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508
[TBL] [Abstract][Full Text] [Related]
3. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
Monroe EW
Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
[TBL] [Abstract][Full Text] [Related]
4. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
Bruttmann G; Pedrali P
J Int Med Res; 1987; 15(2):63-70. PubMed ID: 2884152
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Dubertret L; Murrieta Aguttes M; Tonet J
J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
[TBL] [Abstract][Full Text] [Related]
7. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
Paul E; Bödeker RH
Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
Paul E; Bödeker RH
Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
[TBL] [Abstract][Full Text] [Related]
11. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR
Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of once daily loratadine versus terfenadine in the treatment of allergic rhinitis.
Banov CH
J Int Med Res; 1989; 17(2):150-6. PubMed ID: 2566536
[TBL] [Abstract][Full Text] [Related]
13. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
Oei HD
Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776
[TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo controlled study of terfenadine in the treatment of chronic idiopathic urticaria.
Salisbury J; Bor S; Blair C
Br J Clin Pract; 1987 Aug; 41(8):859-61. PubMed ID: 2896512
[No Abstract] [Full Text] [Related]
15. [Antihistaminic therapy of chronic urticaria. Results of a multicenter study with azatadine and terfenadine].
Neumann Y
Fortschr Med; 1984 Oct; 102(38):967-70. PubMed ID: 6209194
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of chronic allergic skin diseases in a pediatric population.
Lutsky BN; Schuller JL; Cerio R; Chieira ML; Giannetti A; Gonçalves HM; deGroot LJ; Vareltzides A; Guillot B; Lynde CW
Arzneimittelforschung; 1993 Nov; 43(11):1196-9. PubMed ID: 8292064
[TBL] [Abstract][Full Text] [Related]
17. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
Boyle J; Marks P; Gibson JR
J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
[TBL] [Abstract][Full Text] [Related]
18. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis.
Bédard PM; Del Carpio J; Drouin MA; Yang W; Hébert J; Lavoie A; Prévost M; Turenne Y; PetitClerc C; Lorber R
Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796
[TBL] [Abstract][Full Text] [Related]
19. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria.
Nelson HS; Reynolds R; Mason J
Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005
[TBL] [Abstract][Full Text] [Related]
20. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
